go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

Indiana rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $0 · 10th–90th $0$1,148,1540%50%90th$0Professionalmedian $562,341 · 10th–90th $562,341$676,0830%50%90th$562,341$0.0$0.5$10.0$200.0$5.0K$100.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$1,122,018.45
Typical High
$3,890,451.45
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$616,595.00
Anthem BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$562,341.33
Anthem BCBS
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$912,010.84
CareSource
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$676,082.98
Typical High
$1,023,292.99
CareSource
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$562,341.33
Cigna
Setting
Professional
Modifier
Global
Typical Low
$537,031.80
Median
$562,341.33
Typical High
$676,082.98
United
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$977,237.22
Typical High
$1,122,018.45
United
Setting
Professional
Modifier
Global
Typical Low
$346,736.85
Median
$501,187.23
Typical High
$575,439.94